Seminars in Oncology
Volume 33, Supplement 2 , Pages 15-18, February 2006

Clinical Experience With Pemetrexed in Breast Cancer

  • Miguel Martin

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Miguel Martin, Servicio de Oncología Médica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain

Servicio de Oncología Médica, Hospital Universitario San Carlos, Ciudad Universitaria, Madrid, Spain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Martin has served as a consultant to Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Co, and Pharmamar.

PII: S0093-7754(05)00326-X

doi:10.1053/j.seminoncol.2005.07.027

Seminars in Oncology
Volume 33, Supplement 2 , Pages 15-18, February 2006

Article Tools

* Image Usage & Resolution